首页|肝血流超声参数、血清IGFBP-3、miR-9a-5p水平联合检测在肝硬化胃底静脉曲张破裂出血患者再出血诊断中的效能

肝血流超声参数、血清IGFBP-3、miR-9a-5p水平联合检测在肝硬化胃底静脉曲张破裂出血患者再出血诊断中的效能

扫码查看
目的:分析肝血流超声参数、血清胰岛素样生长因子结合蛋白-3(IGFBP-3)、微小RNA-9a-5p(miR-9a-5p)水平联合检测在肝硬化食管胃底静脉曲张破裂出血(EGVB)患者再出血诊断中的效能.方法:选取 2018 年 10 月至 2022 年 3 月该院收治的 124 例肝硬化EGVB患者进行横断面研究,依据治疗后6个月是否发生再出血将其分为出血组70例与未出血组54例.比较两组肝血流超声参数[门静脉内径(PVD)、肝静脉减振指数(HV-DI)、门静脉血流速度(PVV)]、血清IGFBP-3和miR-9a-5p水平,绘制受试者工作特征(ROC)曲线分析肝血流超声参数、血清IGFBP-3、miR-9a-5p水平联合检测在肝硬化EGVB患者再出血诊断中的效能.结果:治疗后 1 个月,两组PVD、HV-DI、血清IGFBP-3、miR-9a-5p水平低于治疗前,但出血组高于未出血组;两组PVV均高于治疗前,但出血组低于未出血组,差异有统计学意义(P<0.05);经ROC曲线分析结果显示,治疗后 1 个月PVD、HV-DI、PVV、IGFBP-3、miR-9a-5p水平单项及联合检测诊断肝硬化EGVB患者再出血的曲线下面积分别为 0.760、0.761、0.764、0.753、0.780、0.930,且联合检测诊断肝硬化EGVB治疗后再出血的效能高于五者单项检测.结论:肝血流超声参数、血清IGFBP-3、miR-9a-5p水平联合检测诊断肝硬化EGVB患者再出血的效能高于五者单项检测.
Efficiency of combined detection of liver blood flow ultrasound parameters,serum IGFBP-3 and miR-9a-5p levels in diagnosis of rebleeding in patients with liver cirrhosis and gastric fundus variceal bleeding
Objective:To analyze efficiency of combined detection of liver blood flow ultrasound parameters,serum insulin-like growth factor binding protein-3(IGFBP-3)and microRNA-9a-5p(miR-9a-5p)levels in diagnosis of rebleeding in patients with liver cirrhosis and esophagogastric variceal bleeding(EGVB).Methods:A cross-sectional study was conducted on 124 liver cirrhosis patients with EGVB admitted to the hospital from October 2018 to March 2022.According to whether rebleeding occurred within 6 months after the treatment,they were divided into bleeding group(70 cases)and non-bleeding group(54 cases).The levels of liver blood flow ultrasound parameters[portal vein diameter(PVD),hepatic vein damping index(HV-DI),portal vein blood flow velocity(PVV)],the serum IGFBP-3 level and the miR-9a-5p level were compared between the two groups.The receiver operating characteristic curve(ROC)was drawn to analyze the efficiency of combined detection of liver blood flow ultrasound parameters,serum IGFBP-3 and miR-9a-5p levels in the diagnosis of rebleeding in patients with liver cirrhosis and EGVB.Results:1 month after the treatment,the levels of PVD,HV-DI and serum IGFBP-3,miR-9a-5p in the two groups were lower than those before the treatment,but those in the bleeding group were higher than those in the non-bleeding group;the PVV levels of the two groups were higher than those before the treatment,but that in the bleeding group was lower than that in the non-bleeding group,and the differences were statistically significant(P<0.05).The ROC curve analysis showed that the area under the curve of single and combined detection of PVD,HV-DI,PVV,IGFBP-3 and miR-9a-5p levels in the diagnosis of rebleeding in patients with liver cirrhosis and EGVB 1 month after the treatment were 0.760,0.761,0.764,0.753,0.780 and 0.930,respectively,and the efficiency of combined detection was higher than that of single detection.Conclusions:The efficiency of combined detection of liver blood flow ultrasound parameters,serum IGFBP-3 and miR-9a-5p levels in the diagnosis of rebleeding in the patients with liver cirrhosis and EGVB is higher than that of single detection of the five.

Liver cirrhosisEsophagogastric variceal bleedingLiver blood flow ultrasound parameterInsulin-like growth factor binding protein-3MicroRNA-9a-5pRebleeding

胡海远

展开 >

南阳医学高等专科学校第三附属医院超声科,河南 南阳 473000

肝硬化 食管胃底静脉曲张破裂出血 肝血流超声参数 胰岛素样生长因子结合蛋白-3 微小RNA-9a-5p 再出血

2024

中国民康医学
中国社会工作协会

中国民康医学

影响因子:0.649
ISSN:1672-0369
年,卷(期):2024.36(9)
  • 12